Search details
1.
Metastatic extraneural glioblastoma diagnosed with molecular testing.
Oncologist
; 2024 Jun 05.
Article
in English
| MEDLINE | ID: mdl-38837109
2.
Prolonged complete response to adjuvant tepotinib in a patient with newly diagnosed disseminated glioblastoma harboring mesenchymal-epithelial transition fusion.
Oncologist
; 2024 May 30.
Article
in English
| MEDLINE | ID: mdl-38815166
3.
The risk and burden of thromboembolic and hemorrhagic events in patients with malignant gliomas receiving bevacizumab.
J Neurooncol
; 167(1): 181-188, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38372903
4.
Characterization of industry relationships in oncology.
Cancer
; 129(18): 2848-2855, 2023 09 15.
Article
in English
| MEDLINE | ID: mdl-37227811
5.
Immunotherapy for Neuro-oncology.
Adv Exp Med Biol
; 1342: 233-258, 2021.
Article
in English
| MEDLINE | ID: mdl-34972967
6.
Neurologic Toxicities of Immunotherapy.
Adv Exp Med Biol
; 1342: 417-429, 2021.
Article
in English
| MEDLINE | ID: mdl-34972978
7.
Development of second primary tumors and outcomes in medulloblastoma by treatment modality: A Surveillance, Epidemiology, and End Results analysis.
Pediatr Blood Cancer
; 67(8): e28373, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32453481
8.
Therapeutic Strategies for Gliomas Associated With Cancer Predisposition Syndromes.
JCO Precis Oncol
; 8: e2300442, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38394467
9.
Outcomes and Pattern of Care for Spinal Myxopapillary Ependymoma in the Modern Era-A Population-Based Observational Study.
Cancers (Basel)
; 16(11)2024 May 25.
Article
in English
| MEDLINE | ID: mdl-38893133
10.
The Role of Immunotherapy in the Treatment of Rare Central Nervous System Tumors.
Curr Oncol
; 30(6): 5279-5298, 2023 05 25.
Article
in English
| MEDLINE | ID: mdl-37366884
11.
Preclinical Models of Low-Grade Gliomas.
Cancers (Basel)
; 15(3)2023 Jan 18.
Article
in English
| MEDLINE | ID: mdl-36765553
12.
Recent Therapeutic Advances in Pituitary Carcinoma.
J Immunother Precis Oncol
; 6(2): 74-83, 2023 May.
Article
in English
| MEDLINE | ID: mdl-37214211
13.
Characterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experience.
Neurooncol Adv
; 5(1): vdad032, 2023.
Article
in English
| MEDLINE | ID: mdl-37114244
14.
Total skin electron beam radiation in a pediatric patient with leukemia cutis: a case report.
J Pediatr Hematol Oncol
; 34(7): 556-8, 2012 Oct.
Article
in English
| MEDLINE | ID: mdl-23007342
15.
Molecular, Histological, and Clinical Characteristics of Oligodendrogliomas: A Multi-Institutional Retrospective Study.
Neurosurgery
; 90(5): 515-522, 2022 05 01.
Article
in English
| MEDLINE | ID: mdl-35179134
16.
A first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma.
CNS Oncol
; 11(2): CNS87, 2022 06 01.
Article
in English
| MEDLINE | ID: mdl-35575067
17.
Intrinsic Interferon Signaling Regulates the Cell Death and Mesenchymal Phenotype of Glioblastoma Stem Cells.
Cancers (Basel)
; 13(21)2021 Oct 21.
Article
in English
| MEDLINE | ID: mdl-34771447
18.
The promise of DNA damage response inhibitors for the treatment of glioblastoma.
Neurooncol Adv
; 3(1): vdab015, 2021.
Article
in English
| MEDLINE | ID: mdl-33738447
19.
A validated integrated clinical and molecular glioblastoma long-term survival-predictive nomogram.
Neurooncol Adv
; 3(1): vdaa146, 2021.
Article
in English
| MEDLINE | ID: mdl-33426529
20.
Clinical characterization of adult medulloblastoma and the effect of first-line therapies on outcome; The MD Anderson Cancer Center experience.
Neurooncol Adv
; 3(1): vdab079, 2021.
Article
in English
| MEDLINE | ID: mdl-34377987